Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics

Cited by (196)

Items 101–196 of 196

  1. Constipation is linked to accelerated cognitive and motor decline in isolated REM sleep behavior disorder
    Kyung Ah Woo, Seo-Yeon Kim, Hyunwoo Nam, Yu Kyeong Kim, Beomseok Jeon, Jee‐Young Lee · 2023 · Parkinsonism & Related Disorders
  2. The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
    Liyan Yao, Yong Yang, Xiaowei Yang, Mohammad J. Rezaei · 2024 · Molecular Neurobiology
  3. Gut microbiota and Parkinson’s disease: potential links and the role of fecal microbiota transplantation
    Maosen Feng, Zhiyan Zou, Pingping Shou, Wei Peng, Mingxue Liu, Xiaoan Li · 2024 · Frontiers in Aging Neuroscience
  4. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen · 2022 · European Journal of Inflammation
  5. The Role of Microbiome in Psychiatric Diseases (Insomnia and Anxiety/Depression) with Microbiological Mechanisms
    Madiha Khan Niazi, Farooq Hassan, Tabussam Tufail, Muhammad Amjed Ismail, Khadija Riaz · 2023 · Advanced Gut & Microbiome Research
  6. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction
    Jianran Hu, Ping Li, Hongmei Zhao, Pengyu Ji, Yanjun Yang, Jianhua Ma, Xin Zhao · 2023 · Journal of Ethnopharmacology
  7. Body mass index in patients with Parkinson’s disease: a systematic review
    Yinghui Li, Yumei Liu, Chuanning Du, Jun Wang · 2024 · Journal of Neurophysiology
  8. The Gut–Brain Axis in Parkinson's Disease
    Virginia Gao, Carl V. Crawford, Jacqueline Burré · 2024 · Cold Spring Harbor Perspectives in Medicine
  9. The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study
    Paulina Gątarek, Małgorzata Pawelczyk, Barbara Bobrowska‐Korczak, Joanna Giebułtowicz, Andrzej R Glabinski, Joanna Kałużna‐Czaplińska · 2025 · International Journal of Molecular Sciences
  10. Administering Lactiplantibacillus fermentum F6 decreases intestinal Akkermansia muciniphila in a dextran sulfate sodium-induced rat colitis model
    Qiuwen He, Tao Zhang, Weiqin Zhang, Cuijiao Feng, Lai‐Yu Kwok, Heping Zhang, Zhihong Sun · 2024 · Food & Function
  11. The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
    Dayamrita Kollaparampil Kishanchand, Athira Krishnan K. A., Krishnapriya Chandrababu, Cyriac Abby Philips, Unnikrishnan Sivan, P. S. Baby Chakrapani · 2025 · Journal of Neuroscience Research
  12. The role of the gut microbiota in neuropsychiatric disorders and therapy
    Fan Zhang, Kang Ding, Linmei Zhang, Dongyao Liu, Xin Dong, Man‐Ni Wang, Fu-Lin Zhou, Yi‐Wei Sun, Wei‐Ku Zhang, Yan Yu et al. · 2025 · Ageing Research Reviews
  13. Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy
    Lucia Boeri, Francesca Donnaloja, Marzia Campanile, Lorenzo Sardelli, Marta Tunesi, Federica Fusco, Carmen Giordano, Diego Albani · 2022 · Neurobiology of Disease
  14. Inflammatory gut as a pathologic and therapeutic target in Parkinson’s disease
    Jea-Young Lee, Zhen-Jie Wang, Alexa Moscatello, Chase Kingsbury, Blaise Cozene, Jeffrey Farooq, Madeline Saft, Nadia Sadanandan, Bella Gonzales‐Portillo, Henry Zhang et al. · 2022 · Cell Death Discovery
  15. Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
    Keaton Stagaman, Matthew J. Kmiecik, Madeleine Wetzel, Stella W. Aslibekyan, Teresa Filshtein Sönmez, Pierre Fontanillas, Adam Auton, Elizabeth Babalola, Robert K. Bell, Jessica Bielenberg et al. · 2024 · Communications Medicine
  16. Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of α-synuclein in a TLR4-dependent manner in STC-1 cells
    Anastazja M. Gorecki, Chidozie C. Anyaegbu, Melinda Fitzgerald, Kathryn A. Fuller, Ryan S. Anderton · 2024 · Methods
  17. Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson’s disease and multiple system atrophy
    Ying Chao, Yuan Li, Hui Zhang, Shimin Pang, Shuwen Hao, Songnian Hu, Lifang Zhao · 2024 · Frontiers in Neuroscience
  18. Specific Bacterial Taxa and Their Metabolite, DHPS, May Be Linked to Gut Dyshomeostasis in Patients with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
    Courtney Jayde Christopher, Katherine Hope Morgan, Christopher Tolleson, Randall Trudell, Roberto Fernandez-Romero, Leanne Rice, Blessing A Abiodun, Zane A. Vickery, Katarina A. Jones, Brittni Woodall et al. · 2025 · Nutrients
  19. Fecal Microbiota Transplantation for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Muhammad Hassan Waseem, Zain Ul Abideen, Areeba Shoaib, Nohela Rehman, Muhammad Osama, Barka Sajid, Rowaid Ahmad, Zara Fahim, Muhammad Ahsan Ansari, Sania Aimen et al. · 2025 · Journal of Central Nervous System Disease
  20. Detection of Volatile Organic Compounds as an emerging strategy for Parkinson’s disease diagnosis and monitoring
    Ilaria Belluomo, Munir Tarazi, Nicholas P Lao–Kaim, Yen Tai, Patrik Španěl, George Bushra Hanna · 2025 · npj Parkinson s Disease
  21. Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics
    Jia Wei Hor, Tzi Shin Toh, Shen‐Yang Lim, Ai Huey Tan · 2024 · Journal of Parkinson s Disease
  22. Stem Cells for Aging-Related Disorders
    Mia C. Borlongan, Jeffrey Farooq, Nadia Sadanandan, Zhen-Jie Wang, Blaise Cozene, Jea-Young Lee, Gary Kenneth Steinberg · 2021 · Stem Cell Reviews and Reports
  23. Intestinal microbiota distribution and changes in different stages of Parkinson's disease: A meta-analysis, bioinformatics analysis and in vivo simulation
    Tingyue Jiang, Yu Wang, Wenxin Fan, Yifan Lu, Ge Zhang, Jiayuan Li, Rui Ma, Mengmeng Liu, Jinli Shi · 2025 · BioScience Trends
  24. The Enteric Nervous System as a Mediator of Microbiota‐Gut‐Brain Interactions in Parkinson's Disease
    Luisa Valdetaro, Maria Carolina Ricciardi, P. G Almeida, Milena Barcza Stockler‐Pinto, Ana Lúcia Tavares Gomes · 2026 · Journal of Neurochemistry
  25. Association between major dietary patterns and Parkinson’s disease risk: a case–control study
    Nafiseh Shokri Mashhadi, Reza Ghiasvand, Awat Feizi, Mohsen Ebrahimi-Monfared, Farhad Vahid, Akram Banijamali · 2023 · Neurological Sciences
  26. Crosstalk between gut microbiome and neuroinflammation in pathogenesis of HIV-associated neurocognitive disorder
    Xue Chen, Jiaqi Wei, Yang Zhang, Yulin Zhang, Tong Zhang · 2024 · Journal of the Neurological Sciences
  27. NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions
    Xiangnan Xu, Michal Lubomski, Andrew J. Holmes, Carolyn M. Sue, Ryan L. Davis, Samuel Müller, Jean Yee Hwa Yang · 2023 · Microbiome
  28. Alterations of Gut Microbiota and Microbial Metabolites in Parkinson’s Disease: A Systematic Review
    Samin Davoody, Kimia Ghazi Vakili, Kimia Jazi, Mobina Fathi, Mahsa Heidari‐Foroozan, Seyed Ali Mofidi, Mahsa Taremi, Amirreza Taherkhani, Sina Azadnajafabad, Fatemeh Hojjatipour et al. · 2025 · Molecular Neurobiology
  29. Gastric microbiota and its role in gastric carcinogenesis
    Xiaowen Jiang, Lei Peng, Li Zhang, Zhexuan Li, Tong Zhou, Jingying Zhang, Wenqing Li, Wei‐Cheng You, Yang Zhang, Kai‐Feng Pan · 2023 · Malignancy Spectrum
  30. Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder
    Shrutikirti Vashishth, Rashmi K. Ambasta, Pravir Kumar · 2024 · Ageing Research Reviews
  31. The role of gut-derived short-chain fatty acids in Parkinson's disease
    Mohamed Jamal Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, Renuka Jyothi S, Hasan Khalid Dabis, G. V. Siva Prasad, Imad Jassim Mohammad, Ahmed Adnan, Ameer Hassan Idan · 2024 · Neurogenetics
  32. Limitations and opportunities in multi-omics integration for neurodevelopmental, neurodegenerative and psychiatric disorders: A systematic review
    Luiza Marques Prates Behrens, Guilherme da Silva Fernandes, Gabriela Flores Gonçalves, Franklin Vinny Medina Nunes, Rafael Diogo Weimer, José Cláudio Fonseca Moreira, Márcio Dorn · 2026 · Neuroscience
  33. Disease modifying therapies for Parkinson's disease: Novel targets
    Nirosen Vijiaratnam, Thomas Foltynie · 2021 · Neuropharmacology
  34. Glycolipids in Parkinson's disease: beyond neuronal function
    Fokion Spanos, Michela Deleidi · 2023 · FEBS Open Bio
  35. Recent Trends in Metabolomics by NMR Spectroscopy
    Giorgio Di Paco, Gaia Meoni, Veronica Ghini, Alessia Vignoli, Leonardo Tenori, Paola Turano, Claudio Luchinat · 2026 · Angewandte Chemie International Edition
  36. Metabolic Disturbances in the Gut-brain Axis of a Mouse Model of MPTP-induced Parkinsonism Evaluated by Nuclear Magnetic Resonance
    Dionísio Pedro Amorim Neto, João Vitor Pereira de Godoy, Katiane Tostes, Beatriz Pelegrini Bosque, Paulla Vieira Rodrigues, Silvana A. Rocco, Mauricio Luis Sforça, Matheus de Castro Fonseca · 2023 · Neuroscience
  37. Neurophysiology of Brain Networks Underlies Symptoms of Parkinson’s Disease: A Basis for Diagnosis and Management
    Martha Teresa Acosta-Mejia, Nelson Villalobos · 2023 · Diagnostics
  38. Plasma trimethylamine N-oxide, carnitine, choline, and betaine distinguish cognition impairment in Parkinson's disease
    Zhaohan Xu, Hucheng Chen, Guoyan Zheng, Wei Zhang, Jing Wang, Jian Zhang, Qing Gao, Jun Wu, Xue Xue · 2025 · Parkinsonism & Related Disorders
  39. The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases
    Naomi M. Fettig, Annie Pu, Lisa C. Osborne, Jennifer L. Gommerman · 2024 · Immunological Reviews
  40. Parkinson’s Disease Through the Lens of Metabolomics: A Targeted Systematic Review on Human Studies (2019–2024)
    Federico Cannas, Karolina Krystyna Kopeć, Natalia Zuddas, Flaminia Cesare Marincola, Giorgio Arcara, Michele Loi, Michele Mussap, Vassilios Fanos · 2025 · Journal of Clinical Medicine
  41. Causal relationship between gut microbiota, lipids, and neuropsychiatric disorders: A Mendelian randomization mediation study
    Nan Zhang, Xiaoyu Dong · 2025 · Journal of Affective Disorders
  42. Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation
    Zhi Chai, Yuxia Ouyang, Anketse Debebe, Mellissa Picker, Wonjun Lee, Seth Fenton, Anouck Becker, Kerstin Augustin-Emmerichs, Andreas Schwiertz, Susanne Nicole Weber et al. · 2025 · Journal of Parkinson s Disease
  43. Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology
    Sufang Liu, Qiang Zhao, Jie Tang, Xianhong Li, Juan Wang, Yuting Zhao, Zhengting Yang, Xin Pan, Rui Hua Xiang, Jing Tian et al. · 2025 · CNS Neuroscience & Therapeutics
  44. Mitochondrial Dysfunction in Parkinson’s Disease: Is Impaired Deuterium Depleted Nutrient Supply by Gut Microbes a Primary Factor?
    Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos · 2025 · Biocell
  45. The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review
    Gloria Carrossa, Valentina Misenti, Sofia Faggin, Maria Cecilia Giron, Angelo Antonini · 2025 · Biomedicines
  46. Microbial diversity in drug-naïve Parkinson’s disease patients
    Eliša Papić, Valentino Rački, Mario Hero, Ana Nyasha Zimani, Mojca Čižek Sajko, Gloria Rožmarić, Nada Starčević Čizmarević, Saša Ostojić, Miljenko Kapović, Goran Hauser et al. · 2025 · PLoS ONE
  47. Parkinson’s disease beyond the brain: implications for treatments
    Setareh Malekian Naeini, Marc Danzell Lopez, Paul E. Fraser, Anurag Tandon · 2025 · Frontiers in Aging Neuroscience
  48. When Gut Hormones Influence Brain Function in Depression
    I.P. Siba, Bruno Jacson Martynhak, Marcela Pereira · 2023 · Applied Biosciences
  49. The Poly-Arginine Peptide R18D Interferes with the Internalisation of α-Synuclein Pre-Formed Fibrils in STC-1 Enteroendocrine Cells
    Anastazja M. Gorecki, Holly L. Spencer, Bruno P. Meloni, Ryan S. Anderton · 2023 · Biomedicines
  50. Secondary analysis reveals gut microbiota differences in patients with Parkinson’s disease and/or cognitive impairment
    Xin Shen, Bing Leng, Shukun Zhang, Lai‐Yu Kwok, Feiyan Zhao, Jia Zhao, Zhihong Sun, Jinbiao Zhang · 2024 · Microbiome Research Reports
  51. Development and validation of nomogram for predicting cognitive frailty with multimorbidity: a cross-sectional study
    Chunbo Guo, Shunyin Liu, Yuehua Liu, Mengxi Zhang, Shan Liu, Liting Zeng, Luo Lu · 2025 · Frontiers in Public Health
  52. Nanotherapeutic Interventions for Parkinson’s Disease: Modulating Pathogenic Mechanisms and Overcoming Therapeutic Obstacles
    Xuanying Yin, Chen Wang, Weisen Lin, Shuiqing Huang, Tongkai Chen · 2026 · International Journal of Nanomedicine
  53. The neurobiology of fatty acids: Metabolism, signaling, and roles in neurodegenerative diseases
    Rocío Rojas, Alicia Pellitero, Betül Arslan, Alberto Pérez‐Samartín, Carlos Matute · 2026 · Progress in Lipid Research
  54. Improved Key Microbial Biomarker Discovery Using Ensemble Statistical Methods
    Walter Pirovano, Yashjit Gangopadhyay, Mirna Lilian Baak, Christiaan de Leeuw, Radhika Bongoni, Eline Suzanne Klaassens · 2025 · Advanced Gut & Microbiome Research
  55. Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson’s disease
    Abbey Figliomeni, Samantha J. Winter, Maddison Y. Abonnel, Jade E. Kenna, Samantha Lodge, Luke Whiley, Andrés Bernal, Jérôme D. Coudert, Jonathan Edward Noonan, Belinda J. Kaskow et al. · 2025 · npj Parkinson s Disease
  56. Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis
    Joshua D. Elford, Elise Jasmijn Heesbeen, Nienke A. van der Plaats, Johan Garssen, Aletta D. Kraneveld, Lucianne Groenink, Paula Perez‐Pardo · 2026 · npj Parkinson s Disease
  57. Gut ecosystem dysfunction in parkinson’s disease: deciphering faecal metabolome-metagenome links for novel diagnostic panels
    Yiwei Qian, Shaoqing Xu, Xiaoqin He, Yiqiu Lai, Yi Zhang, Chengjun Mo, Penghui Ai, Xiaodong Yang, Qin Xiao · 2026 · npj Parkinson s Disease
  58. The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease
    Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Khulood S. Hussein, Arwa Turkistani, Fatimah M. Yousef, Ali Ismail Al-Gareeb, Ahmed M Abdelaziz, Yaser Hosny Ali Elewa, Gaber El‐Saber Batiha · 2026 · Probiotics and Antimicrobial Proteins
  59. Optimizing participant recruitment and retention in clinical studies by hearing the voices of persons with Parkinson's
    Xiao Yue Goh, Cholpon Shambetova, Tzi Shin Toh, Eliza Zhunusova, Yi Wen Tay, Jun Ping Chua, Winn Hui Han, Joanne Yu Li Lim, Ai Huey Tan, Shen‐Yang Lim · 2026 · Journal of Parkinson s Disease
  60. Immunology and microbiome: Implications for motor systems
    Yasamin Mahjoub, Davide Martino · 2023 · Handbook of clinical neurology
  61. Identification of metabolites reproducibly associated with Parkinson’s Disease via meta-analysis and computational modelling
    Ronan M. T. Fleming, Xi Luo, Yanjun Liu, Alexander Balck, Christine Klein · 2023 · Research Square
  62. Machine learning-based meta-analysis reveals gut microbiome alterations associated with Parkinson’s disease
    Stefano Romano, Jakob Wirbel, Rebecca Ansorge, Christian Schudoma, Quinten R. Ducarmon, Arjan Narbad, Georg Zeller · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  63. A Comparative Analysis of the Gut Microbiota in Patients With Parkinson’s Disease Worldwide: A Systematic Review
    Mira Beisembayeva, Yelena Shayakhmetova, Муратбекова Шынар Сабитовна, Irina Li, Eduard Z. Yakupov, Rauan B. Kaiyrzhanov, Marina A. Grigolashvili · 2025 · International Journal of Clinical Practice
  64. Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson’s Disease Pathogenesis and Drug Screening
    Jihong Liu, Wanlin Zhao, Zijuan Zhang, Xilei Ai, Bing Cao, Zhenqiang Zhang, Dongrui Ma · 2025 · Stem Cell Reviews and Reports
  65. Gut microbiota in regulation of neuromuscular coordination
    Souvik Roy, Baibhab Chakraborty, Lopamudra Choudhury · 2025 · Elsevier eBooks
  66. Oral Administrations of Short-Chain Fatty Acids or Probiotics Extend the Survival Times and Mitigate the Neuropathological Damages in the Scrapie-Infected Hamsters
    Yuan Wang, Dong-Lin Liang, Rundong Cao, A Ruhan, Jia-Feng Zeng, Bing Xu, Jiandong Li, Weiwei Zhang, Liping Gao, Kang Xiao et al. · 2025 · Molecular Neurobiology
  67. Metagenomics indicates an interplay of the microbiome and functional pathways in Parkinson’s disease
    Sarah Jaehwa Park, Barış Özdinç, Kathryn Grace Coker, Dana M. Walsh, Devon J. Fox, Samantha Evans, Joshua Farahnik, Kelly S. Moffat, Margaret Boomgaarden, Laurie K. Mischley · 2026 · npj Parkinson s Disease
  68. Taurine modulates gut microbiota and attenuates inflammation in a rotenone-induced mouse model of Parkinson's disease
    Yunbo Zhu, Shuo Wang, Shuang Zhao, Yu Zeng, Jing Li, Pingyue Wang, Zhijie Dou, Tianjun Wang · 2026 · NeuroToxicology
  69. Gut-Derived Metabolites and Cognitive Health: Roles of Short-Chain Fatty Acids and Trimethylamine N-oxide
    Dharmendra Kumar Gupta, Rakesh Kumar · 2026 · Cureus
  70. Examination of shared gut microbiome signatures in aging and Parkinson’s disease
    Teddy Jia Wei Tng, Sarivin Vanan, Eng-King Tan, Li Zeng, Wilson Wen Bin Goh, Hei Sunny Wong, Kah‐Leong Lim · 2026 · Frontiers in Aging Neuroscience
  71. The rising tide of frailty in Parkinson’s disease: a bibliometric study of global research landscape and emerging trends
    Ying Jin, Rui Ren, Xijiang Tian, Dan Ye · 2026 · Frontiers in Neurology
  72. The gut–brain axis in Alzheimer’s and Parkinson’s diseases: a systematic review of microbiota-derived biomarkers and novel therapeutic approaches
    V K Singh, Prerana Gupta, Sanjeev Kumar Jain, Prithpal Singh Matreja · 2026 · Journal of Clinical and Experimental Neuropsychology
  73. Parkinson’s disease and inflammatory bowel disease: exploring the connection between the two
    Xin Zhou, Xinyu Zhang, Huazheng Liang, Yong Bi · 2026 · Ageing and Neurodegenerative Diseases
  74. New insights in non-motor symptoms in Parkinson’s disease
    Cristian Falup‐Pecurariu, Alessandra Fanciulli, Rupam Borgohain, К. Ray Chaudhuri, Vinod Metta · 2024 · Frontiers research topics
  75. Interplay Between Gut-microbiota and Neurodegeneration
    Sumel Ashique, Radheshyam Pal, Shubneesh Kumar, Bharti Verma, Nitish Kumar, Ivan Kahwa, Arshad Farid, Neeraj Mishra, Prashant Kumar, Farzad Taghizadeh‐Hesary · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  76. Associations Between the Microbiome and Neurocognitive and Neuropsychiatric Function
    Rebecca Allred Lundwall · 2024 · Oxford University Press eBooks
  77. Constipation: “Making” or “Marking” motor and cognitive progression already in prodromal synucleinopathy?
    Cristina Simonet, Yaroslau Compta · 2024 · Parkinsonism & Related Disorders
  78. Overcoming our shared challenge
    Sasivimol Virameteekul, Walter Maetzler, Roongroj Bhidayasiri · 2024 · Elsevier eBooks
  79. Diagnostic Value of Short-chain Fatty Acids in Psychoneurology and Methodological Aspects of Quantitative Assessment
    Olga V. Kupriyanova, T. V. Grigoryeva · 2024 · Personalized Psychiatry and Neurology
  80. Integrative Analysis of Faecal Metabolomics and Metagenomics in Parkinson's Disease Patients
    Yiwei Qian, Shaoqing Xu, Xiaoqin He, Yiqiu Lai, Yi Zhang, Chengjun Mo, Penghui Ai, Xiaodong Yang, Qin Xiao · 2024 · SSRN Electronic Journal
  81. Depression in Parkinson’s Disease: A Trajectory Linking Gut Microbiota and Neuroinflammation
    Punit Prasanna Kujur, Manas Ranjan Sahu, Amal Chandra Mondal · 2024 · Integrated science
  82. Glyphosate and the Microbiome
    Norbert Fraeyman · 2025 · Springer eBooks
  83. Gut as a second brain and its role in neurological diseases
    Nitin Kumar, Adithya Ashokan, Arya Singh, Balachandar Vellingiri · 2025 · Elsevier eBooks
  84. Microbiota intestinal y eje intestino-cerebro: una revisión de su interacción con el sistema nervioso central
    Vicente Martinez Cardenas, Vivian Rosario Mena Miranda · 2025 · Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria
  85. Common features in the gut microbiota of underweight and overweight individuals and patients with Parkinson’s disease - a mini-review
    Emilia Kaczorowska, Aleksandra Tarasiuk, Karolina Joanna Ratajczyk, Karolina Wyka, Agata Gajos, Jakub Fichna · 2025 · Pharmacological Reports
  86. Additional file 1 of NEMoE: a nutrition aware regularized mixture of experts model to identify heterogeneous diet-microbiome-host health interactions
    Xu, Xiangnan, Michal Lubomski, Andrew J. Holmes, Sue, Carolyn M., Ryan L. Davis, Muller, Samuel, Jean Yee Hwa Yang · 2023 · Figshare
  87. Recent Trends in Metabolomics by NMR Spectroscopy
    Giorgio Di Paco, Gaia Meoni, Veronica Ghini, Alessia Vignoli, Leonardo Tenori, Paola Turano, Claudio Luchinat · 2026 · Angewandte Chemie
  88. Neuroprotective Effects of Biosynthetic d ‐Calcium Pantothenate and Cyanocobalamin Against MPTP‐Induced Parkinsonism via Microbiota Modulation, Metabolic Homeostasis Restoration, and Endoplasmic Reticulum Stress Inhibition
    Yaru Chen, ZHU Shaohui, Yajie Ruan, Kaiqi Zheng, Jing Wang, Qianqian Guan, Tao Xiong (287683) · 2026 · Food Frontiers
  89. Systematic Review and Meta-Analysis of the Efficacy of Fecal Microbiota Transplantation in Parkinson’s Disease: An Exploration Based on UPDRS and Cognitive Scores
    Benyao Liang, Jie Zou, Xiangyu Mao, Ning Xie, Liang Zhaohui · 2026 · Revista de Neurología
  90. Omics research in Parkinson’s disease: evolution, integrated analysis, pathogenic mechanisms, biomarkers, and therapeutic targets
    Ruizhe Cao, Xue Bai, Huan Zhong · 2026 · Frontiers in Molecular Neuroscience
  91. Akkermansia muciniphila gavage alleviates depression-like behaviors in female A53T α-synuclein transgenic mice
    Shuyu Li, Xingkun Chu, Rui Deng, Wei Zheng, Xinyuan Suo, Guangqiang Sun, Hongchun Liu, Meiyu Geng, Jingwei Tian, Yu Zhang · 2026 · Behavioural Brain Research
  92. Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease
    Huiye Han, Owen Luo, Kevin Li, Shyazana Rahaman, Eunice Unbyul Ok, Li Zhang, Menglu Liang, Lin Huang · 2026 · Frontiers in Cellular and Infection Microbiology
  93. Blood-Mediated Gut–Brain Axis in Parkinson’s Disease: Focus on α-Synuclein Transport and Microbiota Dysbiosis-Induced Inflammation
    Chunjie Xu, Wei Li, Xiaonan Ma, Luyu Han, Guangxu Cui, Jingtong Zhao, Xin Wang, Yingjun Guan · 2026 · Cells
  94. Deciphering the heterogeneity of prodromal α-synucleinopathy: linking brain biotyping and gut dysbiosis in isolated REM sleep behaviour disorder
    Shi Tang, Yuhua Yang, Yanlin Wang, Siyi Gong, Ningning Li, Zhixuan He, Jianzhang Ni, Jing Wang, Yaping Liu, Joey Wing Yan Chan et al. · 2026 · EBioMedicine
  95. Beyond Methodological Noise: Robust Gut Microbiota Signals in Parkinson’s Disease via a Heterogeneous Multi-Algorithmic Framework
    Marcela A. V. Pereira, Tetsu Sakamoto, Renan C. Moioli · 2026 · BioMedInformatics
  96. Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson’s disease
    Nastaran Farshchi Aziz, Sandhya Kortagere · 2026 · Communications Biology